FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+9.47%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$14.3B
AUM Growth
+$14.3B
(+18%)
Cap. Flow
+$1.65B
Cap. Flow
% of AUM
11.55%
Top 10 Holdings %
Top 10 Hldgs %
53.52%
Holding
113
New
19
Increased
34
Reduced
32
Closed
9
Top Buys
| 1 |
APC
Anadarko Petroleum
APC
|
$738M |
| 2 |
CELG
Celgene Corp
CELG
|
$648M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$475M |
| 4 |
RHT
Red Hat Inc
RHT
|
$339M |
| 5 |
AGN
Allergan plc
AGN
|
$167M |
Top Sells
| 1 |
TransUnion
TRU
|
$194M |
| 2 |
Meta Platforms (Facebook)
META
|
$179M |
| 3 |
Booking.com
BKNG
|
$164M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$162M |
| 5 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$159M |
Sector Composition
| 1 | Healthcare | 35.75% |
| 2 | Technology | 18.98% |
| 3 | Communication Services | 14.38% |
| 4 | Industrials | 7.19% |
| 5 | Consumer Discretionary | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Exelixis
EXEL
$9.95B
| $64.1M | 0.42% |
3,000,000
| – | – |
|
|
GBT
52
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $59.2M | 0.38% |
1,125,000
-375,000
| -25% | -$19.7M |
|
53
Liberty Global Class A
LBTYA
$4.03B
| $56.2M | 0.37% |
2,083,977
-1,865,576
| -47% | -$50.4M |
|
54
Arrowhead Research
ARWR
$3.84B
| $53M | 0.34% |
2,000,000
+79,391
| +4% | +$2.1M |
|
55
Fate Therapeutics
FATE
$115M
| $50.8M | 0.33% |
2,500,000
| – | – |
|
|
RDUS
56
DELISTED
Radius Health, Inc.
RDUS
| $49.8M | 0.32% |
2,043,149
| – | – |
|
57
CVS Health
CVS
$93B
| $44.8M | 0.29% |
822,500
+197,500
| +32% | +$10.8M |
|
58
Fox Class B
FOX
$24.4B
| $43.2M | 0.28% |
1,182,500
-1,624,931
| -58% | -$59.4M |
|
59
NXP Semiconductors
NXPI
$57.5B
| $42M | 0.27% |
430,000
-105,000
| -20% | -$10.2M |
|
60
Zymeworks
ZYME
$1.07B
| $38.6M | 0.25% |
1,756,470
+181,470
| +12% | +$3.99M |
|
|
FDC
61
DELISTED
First Data Corporation
FDC
| $38.6M | 0.25% |
+1,425,000
| New | +$38.6M |
|
|
PGNX
62
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $34.2M | 0.22% |
5,543,386
+1,342,566
| +32% | +$8.28M |
|
|
RC
63
Ready Capital
RC
$695M
| $33.4M | 0.22% |
2,243,239
| – | – |
|
64
T-Mobile US
TMUS
$284B
| $31.6M | 0.21% |
+425,780
| New | +$31.6M |
|
65
Fox Class A
FOXA
$26.8B
| $30.6M | 0.2% |
836,400
+127,180
| +18% | +$4.66M |
|
|
BPL
66
DELISTED
Buckeye Partners, L.P.
BPL
| $29.6M | 0.19% |
+719,857
| New | +$29.6M |
|
67
PTC Therapeutics
PTCT
$4.41B
| $27M | 0.18% |
600,000
-100,000
| -14% | -$4.5M |
|
68
CRISPR Therapeutics
CRSP
$4.82B
| $23.6M | 0.15% |
500,000
-225,000
| -31% | -$10.6M |
|
|
QTNT
69
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $23.4M | 0.15% |
+2,500,000
| New | +$23.4M |
|
70
Codexis
CDXS
$218M
| $23M | 0.15% |
1,250,000
| – | – |
|
|
STML
71
DELISTED
Stemline Therapeutics, Inc.
STML
| $23M | 0.15% |
1,500,000
-500,000
| -25% | -$7.66M |
|
|
SINA
72
DELISTED
Sina Corp
SINA
| $22M | 0.14% |
510,000
-140,000
| -22% | -$6.04M |
|
|
ZEAL
73
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $21.6M | 0.14% |
1,000,000
+51,300
| +5% | +$1.11M |
|
|
NVTA
74
DELISTED
Invitae Corporation
NVTA
| $21.2M | 0.14% |
900,000
+600,000
| +200% | +$14.1M |
|
|
TVRD
75
Tvardi Therapeutics, Inc. Common Stock
TVRD
$270M
| $20.5M | 0.13% |
+951,326
| New | +$20.5M |
|